Gene Silencing is a sophisticated molecular mechanism that regulates gene expression by preventing the synthesis of specific proteins encoded by certain genes. This process is crucial for maintaining cellular homeostasis, development, and response to environmental stimuli. Various mechanisms underlie gene silencing, with RNA interference (RNAi) being a prominent one. In RNAi, small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), guide the degradation or translational repression of target messenger RNAs (mRNAs). Another mechanism involves epigenetic modifications, where chemical alterations to DNA or associated histone proteins inhibit gene transcription. Gene silencing plays a pivotal role in controlling the activity of transposons, repetitive sequences, and regulating cellular processes like differentiation and immune response. Harnessing gene silencing technologies has significant implications for medicine, as it can be employed to treat genetic disorders, viral infections, and certain cancers by selectively inhibiting the expression of disease-associated genes. While the potential therapeutic applications are promising, challenges such as specificity, delivery methods, and off-target effects continue to be addressed in ongoing research. As our understanding of gene silencing mechanisms deepens, so does the potential for targeted interventions in diverse fields, from personalized medicine to agriculture.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States